Shanghai, China

Liang Du

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Biotheus Inc., Shanghai Genbase Biotechnology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liang Du. Retrieved from https://idiyas.com/inventor/liang-du-98hjmefw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Liang Du

Introduction

Liang Du is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on antibodies. His expertise and dedication have led to the development of valuable patents that advance medical research and treatment.

Latest Patents

Liang Du holds a patent for an "ANTI-CD73 ANTIBODY AND USE THEREOF." This invention is crucial in the ongoing efforts to develop therapies targeting specific diseases. The patent showcases his ability to create solutions that address pressing health challenges.

Career Highlights

Liang Du is currently employed at Biotheus Inc., a company known for its focus on biopharmaceutical innovations. His role at Biotheus Inc. allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Liang has worked alongside notable colleagues, including Hongyan Zhang and Lina Jin. Their combined expertise fosters a collaborative environment that drives innovation and research within their projects.

Conclusion

Liang Du's work exemplifies the spirit of innovation in biotechnology. His patent and contributions to Biotheus Inc. highlight his commitment to advancing medical science. Through his efforts, he continues to make a meaningful impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…